Related Experiment Video
Updated: Feb 11, 2026

08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
17.5K
A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy
Masahiro Shibata1, Kendall Ham1, Mohammad Obaidul Hoque1
1Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
International Journal of Cancer
|April 27, 2018
Summary
The Yes-associated protein 1 (YAP1) pathway drives cancer growth and immune suppression. Inhibiting YAP1 may enhance cancer therapies and overcome drug resistance by modulating the tumor microenvironment.
Area of Science:
- Oncology
- Molecular Biology
- Immunology
Background:
- The Hippo pathway effector YAP1 promotes cancer progression, stem cell expansion, and drug resistance.
- Immunotherapy, including immune checkpoint blockade, is effective against various cancers.
- Tumor microenvironment (TME) immunosuppression hinders anti-cancer immunity and treatment efficacy.
Purpose of the Study:
- To review the dual roles of YAP1 in cancer development and TME immunosuppression.
- To explore YAP1 as a potential therapeutic target in oncology.
Main Methods:
- Literature review of recent studies on YAP1, cancer, and the immune microenvironment.
- Analysis of evidence linking YAP1 pathways to immunosuppressive cell populations within the TME.
Main Results:
- YAP1 signaling contributes to malignant phenotypes and cancer stem cell populations.
- YAP1 influences immune cells like macrophages, myeloid-derived suppressor cells, and regulatory T-cells to create an immunosuppressive TME.
- Evidence suggests YAP1 activation pathways promote tumor progression and drug resistance.
Conclusions:
- YAP1 plays a significant role in both cancer progression and the establishment of an immunosuppressive TME.
- Targeting YAP1 presents a promising therapeutic strategy to enhance anti-cancer immunity and overcome treatment resistance.
Related Concept Videos
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
Gene Therapy
27.7K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.7K
Group Therapy
460
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
460
Behavior Therapy
732
Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
732
Drug Therapy
304
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
304
Cognitive Therapy
1.3K
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
1.3K

